Echo pharmaceuticals

Echo Pharmaceuticals is focused on the formulation, production and development of pharmaceutical products based on cannabis components. Cannabis-based medicines have a long history and are proven to be effective for the treatment of pain, nausea, spasticity and various other symptoms. Their first product Namisol®, a tablet targeted to relieve the symptoms of multiple sclerosis and neurological pain, has recently passed clinical trial phase 2. 


Go to the website: